Maven Clinic has launched the Maven Clinical Research Institute, a research arm focused on measuring the impact of digital health on women and families. The company says it has produced more than 40 peer-reviewed publications to date, with research partners including Harvard Medical School, Brown University, Posterity, and Oura.
The launch is accompanied by Maven’s inaugural Clinical Impact Report, which examines how its virtual care model affects outcomes for underserved populations. Key findings include a 56% lower risk of cesarean delivery among Black members who met with a Maven doula at least twice, and reduced out-of-pocket costs for LGBTQIA+ members, with 15% reporting savings through Maven’s guidance and support.
“For years, the promise of digital care has raced ahead of the proof,” said Dr. Neel Shah, Chief Medical Officer of Maven Clinic. “Today, data is everywhere – but clarity is scarce. As digital health enters its next chapter, the Maven Clinical Research Institute will define the science that substantiates better outcomes with rigorous explanations of how they are achieved.”
The Institute will be guided by Maven’s Scientific and Community Advisory Boards and includes a Visiting Scientist program that brings academic and clinical experts into focused collaboration on women’s and family health topics.
Maven says it supports more than 28 million lives across 175 countries, with outcomes that include up to a 28% reduction in NICU admissions, up to a 15% reduction in C-section rates, and helping 30% of fertility members achieve pregnancy without assisted reproductive technology. The company says these results translate into an average of $9,600 in savings per birth for employers.
Maven became the first company in women’s health to earn NCQA Health Outcomes Accreditation in 2024. The company has raised more than $425 million in funding.
